In fiscal 2025, which ended May 31, 2025, Cannabis Bioscience International Holdings, Inc. reported revenue of $303,022, up 21.8% from the year before. It recorded a net loss of $548,820. The operating loss came to $421,365, an operating margin of -139.1%. Diluted earnings per share were -$0.00. Over the twelve months ended Feb 28, 2026, revenue was $123,627 and the net loss was $515,290.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Feb 28, 2026
|
FY 2025
May 31, 2025
|
FY 2024
May 31, 2024
|
|---|---|---|---|
| Revenue |
0
-64.1%
|
0
+21.8%
|
0
|
| Cost of revenue |
0
-42.3%
|
0
-12.0%
|
0
|
| Gross profit |
0
-67.4%
|
0
+29.4%
|
0
|
| Selling, general and administrative |
0
-80.5%
|
0
-17.7%
|
0
|
| Operating income |
-0
-26.2%
|
-0
+13.3%
|
-0
|
| Income tax |
—
|
—
|
0
|
| Net income |
-1
-8.9%
|
-1
+15.7%
|
-1
|
| Basic EPS |
-0.00
+0.5%
|
-0.00
+16.7%
|
-0.00
|
| Diluted EPS |
-0.00
+0.5%
|
-0.00
+16.7%
|
-0.00
|
| Weighted average shares, basic |
11,503
+9.5%
|
10,716
+3.9%
|
10,318
|
| Weighted average shares, diluted |
11,503
+9.5%
|
10,716
+3.9%
|
10,318
|
| Other measures | |||
| Interest coverage |
-2.68x
|
-3.09x
|
-3.15x
|
| Margins | |||
| Gross margin |
78.78%
|
86.76%
|
81.68%
|
| Operating margin |
-322.60%
|
-139.05%
|
-195.36%
|
| Profit margin |
-416.81%
|
-181.12%
|
-261.75%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- CBIH (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- CO
- Headquarters
- Yantis, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1411057
- Former names
- CHINA INFRASTRUCTURE CONSTRUCTION Corp (until Aug 24, 2022); FIDELITY AVIATION CORP (until Sep 15, 2009)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.